July 7 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL ANNOUNCES POSITIVE FDA INTERACTION
* SEDANA MEDICAL AB (PUBL) HAS COMPLETED A SUCCESSFUL END OF
PHASE
II MEETING WITH US FOOD AND DRUG ADMINISTRATION
* FDA ACCEPTED CO'S PROPOSALS FOR PHASE III PROGRAM,
INCLUDING
STUDY DESIGN AND PRIMARY ENDPOINTS FOR STUDIES
* THIS POSITIVE OUTCOME MEANS THAT CO CAN ENTER PHASE III IN
LINE
WITH COMMUNICATED SCHEDULE
Source text for Eikon: ID:nWkr4zRln4
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))